The independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapy
- PMID: 26885057
- PMCID: PMC4723902
The independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapy
Abstract
Background: Platelets are involved in multiple links of the process of thrombus formation and development. The aim of this study is to investigate the impact of pretreatment platelet parameters, such as plateletcrit (PCT), platelet mean distribution width (MDW), and mean platelet volume (MPV) in a cohort of patients with locally advanced pancreatic adenocarcinoma treated with a combination of chemotherapy and radiation therapy.
Methods: A retrospective analysis was conducted of 163 locally advanced unresectable consecutive pancreatic adenocarcinoma patients who received chemoradiotherapy in Zhejiang cancer hospital from January 2009 to December 2011. The effects of platelet parameters on overall survival (OS) were assessed using Kaplan-Meier analysis. Independent prognostic factors were identified in the multivariate Cox analysis.
Results: The median of the PC, PCT, MDW, MPV and CRP were 175×10(9), 20.0%, 14.0%, 10.8 fl and 7.0 mg/L, respectively. MDW was positively correlated with PC (r=0.156, P=0.047) and CRP (r=0.591, P<0.001). The median survival time of high MDW group was significantly worse than that of low MDW group (14.0 m Vs 11.0 m, P=0.008). Patients with high PCT were found to have shorter overall survival time (15.0 m Vs 11.0 m, P=0.018). Multivariate analysis indicated that MDW and N stage were two independent prognostic factors for overall survival (P<0.05). Patients with higher MDW had a 1.48-fold increased risk of death compared to those with low MDW.
Conclusions: MDW is an independent negative prognostic factor for overall survival in pancreatic adenocarcinoma patients.
Keywords: Pancreatic adenocarcinoma; platelet; platelet parameters; prognosis.
Figures


Similar articles
-
A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer.Pancreatology. 2019 Mar;19(2):346-351. doi: 10.1016/j.pan.2018.12.010. Epub 2019 Jan 2. Pancreatology. 2019. PMID: 30638854
-
Improved Diagnostic and Prognostic Power of Combined Delta Neutrophil Index and Mean Platelet Volume in Pediatric Sepsis.Ann Clin Lab Sci. 2018 Mar;48(2):223-230. Ann Clin Lab Sci. 2018. PMID: 29678851
-
Prognostic value of mean platelet volume to plateletcrit ratio in patients with osteosarcoma.Cancer Manag Res. 2019 Feb 18;11:1615-1621. doi: 10.2147/CMAR.S193949. eCollection 2019. Cancer Manag Res. 2019. PMID: 30863171 Free PMC article.
-
Diagnostic and Prognostic Value of Monocyte Distribution Width in Sepsis.J Inflamm Res. 2022 Jul 20;15:4107-4117. doi: 10.2147/JIR.S372666. eCollection 2022. J Inflamm Res. 2022. PMID: 35898818 Free PMC article. Review.
-
Monocyte distribution width (MDW) in sepsis.Clin Chim Acta. 2023 Aug 1;548:117511. doi: 10.1016/j.cca.2023.117511. Epub 2023 Aug 9. Clin Chim Acta. 2023. PMID: 37562521 Review.
Cited by
-
Prognostic values of platelet-associated indicators in advanced breast cancer.Transl Cancer Res. 2019 Aug;8(4):1326-1335. doi: 10.21037/tcr.2019.07.28. Transl Cancer Res. 2019. PMID: 35116875 Free PMC article.
-
Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer.Dose Response. 2019 Sep 8;17(3):1559325819874199. doi: 10.1177/1559325819874199. eCollection 2019 Jul-Sep. Dose Response. 2019. PMID: 31523206 Free PMC article.
-
Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis.Onco Targets Ther. 2017 Dec 21;11:59-65. doi: 10.2147/OTT.S147715. eCollection 2018. Onco Targets Ther. 2017. PMID: 29317834 Free PMC article.
-
Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer.Sci Rep. 2018 Aug 7;8(1):11814. doi: 10.1038/s41598-018-29293-x. Sci Rep. 2018. PMID: 30087357 Free PMC article. Clinical Trial.
-
The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer.BMC Gastroenterol. 2017 Dec 20;17(1):163. doi: 10.1186/s12876-017-0685-7. BMC Gastroenterol. 2017. PMID: 29262773 Free PMC article.
References
-
- Connolly GC, Phipps RP, Francis CW. Platelets and cancer-associated thrombosis. Semin Oncol. 2014;41:302–10. - PubMed
-
- Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, Mahmood U, Guha S, Ahmad M, Varadhachary GR, Javle M, Katz MH, Fleming JB, Wolff RA, Crane CH, Krishnan S. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol. 2015;54:971–8. - PubMed
-
- Wang H, Gao J, Bai M, Liu R, Li H, Deng T, Zhou L, Han R, Ge S, Huang D, Ba Y. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Platelets. 2014;25:382–7. - PubMed
-
- Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–72. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous